Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02370238
Title A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
Acronym FRIDA
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dompé Farmaceutici S.p.A
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | ITA | FRA | ESP | CZE | BEL


No variant requirements are available.